SCHEMBL30541622

SCHEMBL30541622

COc1ccc(-c2nc3cnc(Cl)cc3n2C2CC2)cc1OC

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 15/20 0.45
▸ CYP11B1 P15538 12/20 0.45
▸ KDM4E B2RXH2 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ RECQL P46063 1/20 0.40
▸ PDGFRB P09619 1/20 0.40
▸ PDGFRA P16234 1/20 0.40
▸ SLC6A2 P23975 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25365515 1.00 CYP11B2 (0.45) CYP11B2CYP11B1KDM4EHSD17B10NPC1
SCHEMBL31578438 0.77 JAK2 (0.47) CYP11B2CYP11B1
SCHEMBL25366422 0.77 JAK2 (0.47) CYP11B2CYP11B1
SCHEMBL25363473 0.75 ALDH1A1 (0.38) CYP11B2CYP11B1KDM4EALDH1A1HPGD
SCHEMBL25364307 0.74 PRKDC (0.37) CYP11B2CYP11B1KDM4EHSD17B10NPC1
SCHEMBL25365595 0.73 ALDH1A1 (0.39) CYP11B2CYP11B1KDM4EHSD17B10NPC1
SCHEMBL25364198 0.73 TGFBR1 (0.37) CYP11B2CYP11B1KDM4EALDH1A1HPGD
SCHEMBL25367831 0.72 TLR9 (0.38) CYP11B2CYP11B1KDM4EHSD17B10NPC1
SCHEMBL20337775 0.71 CYP11B1 (0.70) CYP11B2CYP11B1
SCHEMBL30777241 0.71 CYP11B1 (0.70) CYP11B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479407-A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 Bristol-Myers Squibb Company (US) 2024-12-25 — — EP disclosed
WO-2023159153-A1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 BRISTOL-MYERS SQUIBB COMPANY (US) 2023-08-24 — — WO disclosed
Send feedback